Observational studyFrontiers in immunology2021

Diversity of Dominant Peripheral T Cell Receptor Clone and Soluble Immune Checkpoint Proteins Associated With Clinical Outcomes Following Immune Checkpoint Inhibitor Treatment in Advanced Cancers.

Ye Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.